What is GRI Bio Inc. (GRI) stock price today?

GRI Bio Inc. (GRI) currently trades at $2.18 per share. The stock has a market capitalization of $3.41M and a P/E ratio of —x.

Is GRI stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, GRI Bio Inc. has a Smart Value Score of 26/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 2/9 and Altman Z-Score is -10.73.

Is GRI Bio Inc. financially healthy?

GRI Bio Inc.'s Piotroski F-Score is 2/9 (weak financial health). The Altman Z-Score of -10.73 places it in the distress.

GRI

GRI Bio Inc.

NASDAQ: GRI · HEALTHCARE · BIOTECHNOLOGY

$2.18

-2.25% today

Updated 2026-04-30

Market cap

$3.41M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-121.80

Dividend yield

—

52W range

$2 – $80

Volume

0.1M

Market cap

$3.41M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-121.80

Dividend yield

—

52W range

$2 – $80

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.5

Quality

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

-10.7

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$160.00

+7239.79%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.01x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Altman Z -10.73 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-2.97M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$21.77M	$22.54M	$0.00	$0.00
Net income	$-3.22M	$-13.04M	$-8.21M	$-11.96M	$-2.66M
EPS	—	—	—	—	$-121.80
Free cash flow	$-1.09M	$-9.00M	$-8.61M	$-10.19M	$-2.97M
Profit margin	—	-59.89%	-36.41%	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
GRI	$3.41M	26	4.3	3.0	5.0	6.5	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

GRI Bio Inc. trades at $2.18. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -10.73, it sits in the distress.

Frequently asked questions

What is GRI Bio Inc.'s stock price?

GRI Bio Inc. (GRI) trades at $2.18.

Is GRI Bio Inc. overvalued?

Smart Value Score 26/100 (Grade F, Strong Sell).

What is the price target of GRI Bio Inc. (GRI)?

The analyst target price is $160.00, representing +7239.8% upside from the current price of $2.18.

Piotroski F-Score?

2/9 — weak financial health.

Altman Z-Score?

-10.73 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.gribio.com

Quick metrics

P/S ratio—

ROE-238.20%

Beta-1.24

50D MA$2.47

200D MA$28.24

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

GRI vs LLY →GRI vs JNJ →GRI vs ABBV →Stock screener →